Androgen sensitivity in COVID-19 and antiandrogens: Prospective data are still needed.

Ianhez, Mayra; Ramos, Paulo Müller; Goren, Andy; Miot, Hélio Amante

Ianhez, Mayra; Ramos, Paulo Müller; Goren, Andy; Miot, Hélio Amante.

Ianhez M; Department of Tropical Medicine and Dermatology, Federal University of Goiás, Goiânia, Goiás, Brazil.
Ramos PM; Department of Dermatology and Radiotherapy, São Paulo State University-UNESP, Botucatu, São Paulo, Brazil.
Goren A; Applied Biology, Irvine, CA, USA.
Miot HA; Department of Dermatology and Radiotherapy, São Paulo State University-UNESP, Botucatu, São Paulo, Brazil.

Dermatol Ther ; 33(6): e14166, 2020 11.

Article in English | MEDLINE | ID: covidwho-695863

Subject(s)

Androgen Antagonists/therapeutic use; COVID-19/epidemiology; Prostatic Neoplasms/drug therapy; SARS-CoV-2; Adult; Aged; Androgens/physiology; Humans; Male; Middle Aged; Prospective Studies; Serine Endopeptidases/physiology; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Prostatic Neoplasms / SARS-CoV-2 / COVID-19 / Androgen Antagonists Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Humans / Male / Middle aged Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.14166

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google